Trial Profile
Investigation of interindividual factors in cetuximab pharmacokinetics and clinical responses in Japanese head and neck cancer patients using LC-MS/MS method
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2022
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Head and neck cancer
- Focus Pharmacokinetics
- 20 Apr 2017 New trial record